Correspondence 0001013762-23-005672 from ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343) (ATHE)
ALTERITY THERAPEUTICS LTD (ATHE, PRNAF) (CIK 0001131343)
Date: Oct. 23, 2023 · CIK: 0001131343 · Accession: 0001013762-23-005672
AI Filing Summary & Sentiment
File numbers found in text: 333-274816
Letter
Alterity Therapeutics Ltd.
October 23, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Cindy Polynice
Re: Alterity Therapeutics Ltd.
Registration Statement on Form F-3
File No. No. 333-274816
Ms. Polynice:
The undersigned, on behalf of Alterity Therapeutics Ltd. (“Alterity”), issuer of the securities covered by the above-referenced Registration Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m. Washington, D.C. time on Wednesday October 25, 2023, or as soon thereafter as possible.
Management of Alterity is aware of its responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the disposition of the securities covered by the above-referenced Registration Statement.
Thank you very much for your courtesy in this matter.
Very truly yours,
/s/ Kathryn Andrews
Show Raw Text
CORRESP
1
filename1.htm
Alterity Therapeutics Ltd.
October 23, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Attn: Cindy Polynice
Re: Alterity Therapeutics Ltd.
Registration Statement on Form F-3
File No. No. 333-274816
Ms. Polynice:
The undersigned, on behalf
of Alterity Therapeutics Ltd. (“Alterity”), issuer of the securities covered by the above-referenced Registration Statement,
hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission
at 4:00 p.m. Washington, D.C. time on Wednesday October 25, 2023, or as soon thereafter as possible.
Management of Alterity
is aware of its responsibilities under the Securities Act of 1933 and the Securities Exchange Act of 1934 as they relate to the disposition
of the securities covered by the above-referenced Registration Statement.
Thank you very much for
your courtesy in this matter.
Very truly yours,
/s/ Kathryn Andrews
Kathryn Andrews
Chief
Financial Officer